v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities    
Net income $ 158,391 $ 176,072
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 74,397 71,894
Gain on sale of assets (29) (5,567)
Gain on sales-type leases 0 (24,677)
Goodwill impairment 0 11,034
Amortization of deferred charges 2,863 2,992
Equity-based compensation expense 1,493 1,856
Equity in losses of equity method investments 22,084 0
(Increase) decrease in operating assets:    
Accounts receivable—trade (174) 3,020
Accounts receivable—affiliates (16,643) 6,465
Prepaid and other current assets 2,264 2,452
Increase (decrease) in operating liabilities:    
Accounts payable—trade 2,586 3,202
Accounts payable—affiliates 5,844 (3,515)
Accrued interest 6,664 (6,288)
Deferred revenue (5,572) (3,702)
Accrued property taxes 5,089 4,885
Other current liabilities (20) 183
Turnaround expenditures (24,728) (1,251)
Other, net 3,988 1,719
Net cash provided by operating activities 238,497 240,774
Cash flows from investing activities    
Additions to properties and equipment (31,194) (78,592)
Acquisition of Sinclair Transportation (328,955) 0
Investment in Osage Pipe Line Company, LLC (5,000) 0
Proceeds from sale of assets 37 7,365
Distributions in excess of equity in earnings of equity investments 4,724 3,517
Net cash used for investing activities (360,388) (67,710)
Cash flows from financing activities    
Borrowings under credit agreement 460,000 210,500
Repayments of credit agreement borrowings (594,000) (283,500)
Proceeds from issuance of debt 400,000 0
Contributions from noncontrolling interests 0 21,285
Distributions to HEP unitholders (125,669) (112,384)
Distributions to noncontrolling interests (7,308) (8,743)
Payments on finance leases (2,700) (2,666)
Deferred financing costs (6,541) (6,661)
Purchase of units for incentive grants (334) 0
Units withheld for tax withholding obligations (217) (69)
Other (170) 0
Net cash provided (used) by financing activities 123,061 (182,238)
Cash and cash equivalents    
Increase (decrease) for the period 1,170 (9,174)
Beginning of period 14,381 21,990
End of period 15,551 12,816
Supplemental disclosure of cash flow information    
Cash paid during the period for interest $ 47,941 $ 44,147